Back to Results
First PageMeta Content
QuantiFERON / Latent tuberculosis / Tuberculosis diagnosis / Mantoux test / Bacillus Calmette-Guérin / Tuberculin / T-SPOT.TB / ESAT-6 / Clonal anergy / Tuberculosis / Medicine / Health


NORTH CAROLINA GUIDELINES FOR THE USE OF INTERFERON GAMMA RELEASE ASSAYS (IGRAS) IN TUBERCULOSIS DIAGNOSIS
Add to Reading List

Document Date: 2012-05-02 14:00:37

Open Document

File Size: 260,78 KB

Share Result on Facebook

Company

Interpretation (“Positive” “Negative” “Indeterminate”) Management / IGRAs / TB / /

Country

United States / /

Facility

Hospital Epidemiology / /

IndustryTerm

imperfect tools / healthcare / diagnostic algorithms / healthcare workers / treatment for rheumatic disease / /

MedicalCondition

TB / active TB disease / HIV / rheumatic disease / TB disease / TB infection / MS / remote TB infection / disease / TB cervical lymphadenitis / active tuberculosis / active TB / latent TB infection / IN TUBERCULOSIS DIAGNOSIS Background Interferon gamma release assays / infection / nontuberculous mycobacterial lymphadenitis / tuberculosis / /

MedicalTreatment

immunosuppression / /

MusicGroup

Yes / /

Organization

Food and Drug Administration / N.C. Division of Public Health / /

Person

Myra Allen / David Weber / Kitty Herrin / Julie Luffman / Edward Robinson / Amina Ahmed / Melissa Miller / Paul Cook / Ann Mosher / Arlene Seña / Ellen Fortenberry / Screening / Richard Frothingham / Ashley Ewing / Emily Sickbert-Bennett / Elizabeth Zeringue / Jason Stout / David P. Holland / Christopher Ohl / Carol Hamilton / Edward Hendershot / /

/

Position

Program Manager / Consultant / Nurse / Chair / Controller / /

ProvinceOrState

North Carolina / /

PublishedMedium

Infection Control and Hospital Epidemiology / PLoS ONE / Annals of Internal Medicine / American Journal of Respiratory and Critical Care Medicine / /

URL

http /

SocialTag